跳至主要内容
临床试验/NL-OMON41376
NL-OMON41376已完成4 期

Interbody fusion devices in the treatment of cervicobrachial syndrome; a blinded randomised trial of cancellous structured ceramic (CSC) versus PEEK cages. - CASCADE Trial

Amedica Corporation0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Age between 18 - 75 years.
  • * Radicular signs and symptoms in one or both arms (i.e., pain, paraesthesiae or paresis in a specific nerve root distribution) or symptoms and signs of acute or chronic myelopathy.
  • * At least 8 weeks prior conservative treatment (i.e., physical therapy, pain medication).
  • * Radiographic diagnosis of cervical disc herniation and/or osteophyte at 1 level (C3-C4 to C7-T1) in accordance with clinical signs and symptoms.
  • * Written informed consent .

排除标准

  • * Previous cervical surgery (either anterior or posterior).
  • * Increased motion on dynamic studies (> 3 mm).
  • * Severe segmental kyphosis of the involved disc level (> 7 degrees).
  • * Patient cannot be imaged with MRI.
  • * Neck pain only (without radicular or medullary symptoms).
  • * Infection.
  • * Metabolic and bone diseases (osteoporosis, severe osteopenia).
  • * Neoplasma or trauma of the cervical spine.
  • * Spinal anomaly (Klippel Feil, Bechterew, OPLL).
  • * Severe mental or psychiatric disorder.
  • * Inadequate Dutch language.
  • * Planned (e)migration abroad in the year after inclusion.

研究者

发起方
Amedica Corporation

相似试验